Citation Impact
Citing Papers
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
2014 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
Outcome of Watchful Waiting in Asymptomatic Severe Mitral Regurgitation
2006
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
2007 StandoutNobel
Determination of Clinical Outcome in Mitral Regurgitation With Cardiovascular Magnetic Resonance Quantification
2016
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy
2001 StandoutNobel
Cardiovascular prevention and blood pressure reduction
2003
Prosthetic Heart Valves
1996
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
2010 Standout
Valvular Heart Disease
1997
Echocardiographic markers for mitral valve surgery to preserve left ventricular performance in mitral regurgitation
2000
Carvedilol improves left ventricular function and symptoms in chronic heart failure: A double-blind randomized study
1995
Meta-analysis of effect of beta-blocker therapy on mortality in patients with New York Heart Association class IV chronic congestive heart failure
2000
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
1996 Standout
Analysis of Randomized Controlled Trials on the Effect of Magnitude of Heart Rate Reduction on Clinical Outcomes in Patients With Systolic Chronic Heart Failure Receiving Beta-Blockers
2008
Role of Tumour Necrosis Factor-?? in the Progression of Heart Failure
2000
Prospects for Cardiovascular Research
2001 StandoutNobel
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008
Contemporary trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-Saharan Africa
2007
Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation. Sotalol vs bisoprolol
2001
Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
2005 Standout
Percutaneous Repair or Surgery for Mitral Regurgitation
2011 Standout
Exercise Standards for Testing and Training
2013 Standout
Management of multiple valve disease
2010
The burden of non-communicable diseases in South Africa
2009 Standout
Hemodynamic effects of inhaled nitric oxide in women with mitral stenosis and pulmonary hypertension
2001
Transcatheter coil occlusion of perivalvular mitral leaks associated with severe hemolysis
2000
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
Levels of sP-selectin and hs-CRP Decrease with Dietary Intervention with Selenium and Coenzyme Q10 Combined: A Secondary Analysis of a Randomized Clinical Trial
2015 StandoutNobel
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
Predicting left ventricular dysfunction after valve repair for mitral regurgitation due to leaflet prolapse: additive value of left ventricular end-systolic dimension to ejection fraction
2011
Reduced anticoagulation after mechanical aortic valve replacement: Interim results from the Prospective Randomized On-X Valve Anticoagulation Clinical Trial randomized Food and Drug Administration investigational device exemption trial
2014
Pathophysiology and management of multivalvular disease
2016
Review of Trials in Chronic Heart Failure Showing Broad-Spectrum Anti-Inflammatory Approaches
2005
Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves
2001
Managing Asymptomatic Patients With Chronic Mitral Regurgitation
1995
Multiple and Mixed Valvular Heart Diseases
2018
Survival Implication of Left Ventricular End-Systolic Diameter in Mitral Regurgitation Due to Flail Leaflets
2009
Effect of Carvedilol on Survival in Severe Chronic Heart Failure
2001 Standout
Cardiac Resynchronization in Chronic Heart Failure
2002 Standout
Two functionally distinct α2-adrenergic receptors regulate sympathetic neurotransmission
1999 StandoutNatureNobel
Assessment of tricuspid valve annulus size, shape and function using real-time three-dimensional echocardiography
2006
Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: A randomized, double-blind, placebo-controlled study
1994
Effects of Multisite Biventricular Pacing in Patients with Heart Failure and Intraventricular Conduction Delay
2001 Standout
Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade
1995
Burden of valvular heart diseases: a population-based study
2006 Standout
Tricuspid annuloplasty prevents right ventricular dilatation and progression of tricuspid regurgitation in patients with tricuspid annular dilatation undergoing mitral valve repair
2010
The role of tumor necrosis factor in the pathophysiology of heart failure
2000
Mechanism of Action of Beta-Blocking Agents in Heart Failure
1997
Myocardial Expression of Fas and Recovery of Left Ventricular Function in Patients With Recent-Onset Cardiomyopathy
2005
Antithrombotic Therapy in Valvular Heart Disease—Native and Prosthetic
2004
Sex differences in immune responses
2016 Standout
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
2004 Standout
Left Ventricle and Left Atrium Remodeling after Mitral Valve Replacement in Case of Mixed Mitral Valve Disease of Rheumatic Origin
2010
Mitral mechanical replacement in young rheumatic women: Analysis of long-term survival, valve-related complications, and pregnancy outcomes over a 3707-patient-year follow-up
2005
Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy
1994
How should left atrial size be reported? Comparative assessment with use of multiple echocardiographic methods
2004
Is there an outcome penalty linked to guideline-based indications for valvular surgery? Early and long-term analysis of patients with organic mitral regurgitation
2015
Treatment of Infections Associated with Surgical Implants
2004 Standout
Biomarkers in Heart Failure
2008 Standout
Discrete subaortic stenosis in adults: increased prevalence and slow rate of progression of the obstruction and aortic regurgitation
2001
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
Linkage of β1-adrenergic stimulation to apoptotic heart cell death through protein kinase A–independent activation of Ca2+/calmodulin kinase II
2003 StandoutNobel
Myocarditis
2009 Standout
Interleukin-6 Signaling, Soluble Glycoprotein 130, and Inflammation in Heart Failure
2014
Therapy of Ischemic Cardiomyopathy With the Immunomodulating Agent Pentoxifylline
2004
Dual modulation of cell survival and cell death by β 2 -adrenergic signaling in adult mouse cardiac myocytes
2001 StandoutNobel
Double-Blind, Placebo-Controlled Study of the Long-term Efficacy of Carvedilol in Patients With Severe Chronic Heart Failure
1995
The Effect of Testosterone Replacement on Endogenous Inflammatory Cytokines and Lipid Profiles in Hypogonadal Men
2004
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Percutaneous balloon mitral commissurotomy during pregnancy.
1997
Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Infliximab, a Chimeric Monoclonal Antibody to Tumor Necrosis Factor-α, in Patients With Moderate-to-Severe Heart Failure
2003 Standout
Impact of Preoperative Symptoms on Survival After Surgical Correction of Organic Mitral Regurgitation
1999
Long-term Outcome of Cardiac Surgery in Patients With Mitral Stenosis and Severe Pulmonary Hypertension
1995
Long-Term Prognosis of Isolated Significant Tricuspid Regurgitation
2010
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
β-Adrenergic Receptor Blockade in Chronic Heart Failure
2000
G Protein-Coupled Receptors: Functional and Mechanistic Insights Through Altered Gene Expression
1998 StandoutNobel
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Linkage of β1-adrenergic stimulation to apoptotic heart cell death through protein kinase A–independent activation of Ca2+/calmodulin kinase II
2003 StandoutNobel
Safety and Efficacy of a Soluble P75 Tumor Necrosis Factor Receptor (Enbrel, Etanercept) in Patients With Advanced Heart Failure
1999
Gene-Targeted Mice Lacking the Trex1 (DNase III) 3′→5′ DNA Exonuclease Develop Inflammatory Myocarditis
2004 StandoutNobel
Spontaneous Conversion and Maintenance of Sinus Rhythm by Amiodarone in Patients With Heart Failure and Atrial Fibrillation
1998
Double-Blind, Placebo-Controlled Study of the Effects of Carvedilol in Patients With Moderate to Severe Heart Failure
1996
Intracoronary Adenovirus-Mediated Delivery and Overexpression of the β 2 -Adrenergic Receptor in the Heart
2000 StandoutNobel
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Reciprocal In Vivo Regulation of Myocardial G Protein–Coupled Receptor Kinase Expression by β-Adrenergic Receptor Stimulation and Blockade
1998 StandoutNobel
Transgenic Manipulation of Myocardial G Protein–Coupled Receptors and Receptor Kinases
1996 StandoutNobel
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
Nebivolol
2009
Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators.
1994
Clinical Effects of β-Adrenergic Blockade in Chronic Heart Failure
1998
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Medical Therapy Can Improve the Biological Properties of the Chronically Failing Heart
1996
Results of Targeted Anti–Tumor Necrosis Factor Therapy With Etanercept (ENBREL) in Patients With Advanced Heart Failure
2001
Preservation of myocardial β-adrenergic receptor signaling delays the development of heart failure after myocardial infarction
2000 StandoutNobel
B-Type Natriuretic Peptide in Organic Mitral Regurgitation
2005
Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial
2010 Standout
Contemporary Approach to Aortic and Mitral Regurgitation
2003
Works of Daniel Skudicky being referenced
Effects of pentoxifylline on cytokine profiles and left ventricular performance in patients with decompensated congestive heart failure secondary to idiopathic dilated cardiomyopathy
2002
Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy
1998
Results of percutaneous balloon mitral valvotomy in young adults
1993
Efficacy of mitral balloon valvotomy in reducing the severity of associated tricuspid valve regurgitation
1994
Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1
2000
Efficacy of Different Drug Classes Used to Initiate Antihypertensive Treatment in Black Subjects
2001
Frequency of prosthetic valve-related complications with very low level warfarin anticoagulation combined with dipyridamole after valve replacement using St. Jude Medical prostheses
1994
Frequency and severity of intravascular hemolysis after left-sided cardiac valve replacement with medtronic hall and St. Jude medical prostheses, and influence of prosthetic type, position, size and number
1993
Long-term (3-month) effects of a new beta-blocker (nebivolol) on cardiac performance in dilated cardiomyopathy
1993
Effectiveness of Amiodarone and electrical cardioversion for chronic rheumatic atrial fibrillation after mitral valve surgery
1993
Effects of severe pulmonary hypertension on outcome of balloon mitral valvotomy
1992
Diagnostic value of transesophageal versus transthoracic echocardiography in discrete subaortic stenosis
1992
Relationship between treatment-induced changes in left ventricular mass and blood pressure in black African hypertensive patients. Results of the Baragwanath trial
2002
Beneficial Effects of Pentoxifylline in Patients With Idiopathic Dilated Cardiomyopathy Treated With Angiotensin-Converting Enzyme Inhibitors and Carvedilol
2001
Relationship Between Treatment-Induced Changes in Left Ventricular Mass and Blood Pressure in Black African Hypertensive Patients
2002
Long-Term Follow-Up of Rheumatic Patients Undergoing Left-Sided Valve Replacement With Tricuspid Annuloplasty—Validity of Preoperative Echocardiographic Criteria in the Decision to Perform Tricuspid Annuloplasty
1998
Pulmonary hypertension is a contraindication to β-blockade in patients with severe mitral stenosis
1993
Time-Related Changes in Left Ventricular Function After Double Valve Replacement for Combined Aortic and Mitral Regurgitation in a Young Rheumatic Population
1997
Long-Term Follow-Up of St. Jude Medical Prosthesis in a Young Rheumatic Population Using Low-Level Warfarin Anticoagulation: An Analysis of the Temporal Distribution of Causes of Death
1998
Prediction of outcome after valve replacement for rheumatic mitral regurgitation in the era of chordal preservation.
1994